Sanofi Detailed Consensus >> Business P&L
Last Update: 2021-07-21

Please note:

“The historic Q2 and FY 2020 numbers below reflect the changes and restatements of the General Medicine segment.”

KPI[EUR m]Q2 2020FY 2020Q2 2021 EFY 2021 EFY 2022 EFY 2023 EFY 2024 EFY 2025 E
Net salesNumber of Estimates171818181818
Net salesHighest8,59037,52440,90443,26546,54551,021
Net salesConsensus (Mean)8,20736,0418,40836,86138,84840,28442,17344,507
Net salesLowest8,20336,24637,48537,97238,97840,177
Other revenuesNumber of Estimates171818181818
Other revenuesHighest3451,5001,6141,6901,7701,854
Other revenuesConsensus (Mean)2311,3282771,3851,4511,5041,5501,595
Other revenuesLowest2291,2881,3271,3551,3801,406
Cost of salesNumber of Estimates171818181818
Cost of salesHighest-2,383-11,342-11,109-11,463-11,248-11,512
Cost of salesConsensus (Mean)-2,660-12,104-2,678-12,089-12,349-12,704-13,135-13,718
Cost of salesLowest-2,846-12,350-13,018-13,691-14,457-15,496
Gross ProfitNumber of Estimates171818181818
Gross ProfitHighest6,16226,52529,32731,06133,62737,120
Gross ProfitConsensus (Mean)5,77825,2656,00626,15727,94929,08430,58932,385
Gross ProfitLowest5,86725,77127,19627,77928,74529,786
- as % of net sales (gross margin)Number of Estimates171818181818
- as % of net sales (gross margin)Highest73.772.674.474.575.075.1
- as % of net sales (gross margin)Consensus (Mean)70.470.171.471.
- as % of net sales (gross margin)Lowest70.070.371.170.971.371.0
R&D expensesNumber of Estimates171818181818
R&D expensesHighest-1,331-5,431-5,440-5,483-5,540-5,597
R&D expensesConsensus (Mean)-1,352-5,529-1,391-5,674-5,721-5,808-5,913-6,037
R&D expensesLowest-1,466-5,840-5,948-6,131-6,295-6,517
SG&A expensesNumber of Estimates171818181818
SG&A expensesHighest-2,013-8,649-6,166-8,434-8,543-8,703
SG&A expensesConsensus (Mean)-2,265-9,390-2,201-9,204-8,971-9,207-9,326-9,510
SG&A expensesLowest-2,270-9,425-9,490-9,829-10,380-10,929
Other current operating income/expenseNumber of Estimates171818181818
Other current operating income/expenseHighest-200-673-794-883-964-1,055
Other current operating income/expenseConsensus (Mean)-8-562-284-1,076-1,528-1,909-2,260-2,585
Other current operating income/expenseLowest-387-1,440-1,954-2,476-2,893-3,267
Share of profit/loss of associatesNumber of Estimates171818181818
Share of profit/loss of associatesHighest73273108129149
Share of profit/loss of associatesConsensus (Mean)21621625344045
Share of profit/loss of associatesLowest-8-29-25-700
Net income attributable to non-controlling interestsNumber of Estimates171818181818
Net income attributable to non-controlling interestsHighest-5-30-10-10-10-10
Net income attributable to non-controlling interestsConsensus (Mean)-9-38-9-39-35-35-35-35
Net income attributable to non-controlling interestsLowest-15-58-48-49-50-51
Business operating incomeNumber of Estimates171818181818
Business operating incomeHighest2,28710,42914,42913,12614,68916,940
Business operating incomeConsensus (Mean)2,1469,7622,12410,18111,71912,15713,09414,262
Business operating incomeLowest1,9819,88211,08911,43012,03112,576
- as % of net sales (operating margin)Number of Estimates171818181818
- as % of net sales (operating margin)Highest26.928.237.030.932.233.5
- as % of net sales (operating margin)Consensus (Mean)
- as % of net sales (operating margin)Lowest23.627.
Financial income & expenseNumber of Estimates171818181818
Financial income & expenseHighest-62-247-200-150-7737
Financial income & expenseConsensus (Mean)-92-337-82-331-296-269-237-208
Financial income & expenseLowest-103-429-397-369-393-403
- % tax rateNumber of Estimates171818181818
- % tax rateHighest-20.9-20.4-16.6-20.5-20.4-20.3
- % tax rateConsensus (Mean)-22.0-22.0-21.2-21.1-20.9-21.1-21.1-21.1
- % tax rateLowest-22.9-22.0-22.0-22.0-22.0-22.0
Business net incomeNumber of Estimates171818181818
Business net incomeHighest1,7427,98411,85810,15011,42513,222
Business net incomeConsensus (Mean)1,6017,3471,6087,7719,0449,37710,14411,091
Business net incomeLowest1,4797,6038,5198,8209,2669,719
- as % of net sales (net profit margin)Number of Estimates171818181818
- as % of net sales (net profit margin)Highest20.521.630.424.124.925.9
- as % of net sales (net profit margin)Consensus (Mean)19.520.419.121.123.323.324.024.9
- as % of net sales (net profit margin)Lowest17.720.622.322.423.123.2
Number of sharesNumber of Estimates161717171717
Number of sharesHighest1,2611,2601,2561,2571,2581,259
Number of sharesConsensus (Mean)1,2521,2541,2511,2511,2501,2491,2461,243
Number of sharesLowest1,2431,2431,2391,2301,2181,205
Business EPS (in EUR)Number of Estimates171818181818
Business EPS (in EUR)Highest1.396.397.568.169.1810.62
Business EPS (in EUR)Consensus (Mean)1.285.861.
Business EPS (in EUR)Lowest1.186.066.797.047.407.76
Dividend Per Share (in EUR)Number of Estimates-1515151515
Dividend Per Share (in EUR)Highest-3.393.944.264.695.18
Dividend Per Share (in EUR)Consensus (Mean)-3.20-3.293.483.663.854.06
Dividend Per Share (in EUR)Lowest-3.203.303.353.413.46

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.